Efficacy of aminaftone in a rat model of monocrotaline-induced pulmonary hypertension
- 30 September 2011
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 667 (1-3), 287-291
- https://doi.org/10.1016/j.ejphar.2011.05.060
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A meta-analysis of randomized controlled trials in pulmonary arterial hypertensionEuropean Heart Journal, 2008
- Effects of aminaftone 75 mg TID on soluble adhesion molecules: A 12-week, randomized, open-label pilot study in patients with systemic sclerosisClinical Therapeutics, 2008
- Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Effect of β-adrenergic and renin–angiotensin system blockade on myocyte apoptosis and oxidative stress in diabetic hypertensive ratsLife Sciences, 2007
- BMPR-IIheterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndromeThe American Journal of Cardiology, 1993
- Endothelins, peptides with potent vasoactive properties, are produced by human macrophages.The Journal of Experimental Medicine, 1990
- Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells.JCI Insight, 1989
- Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seedsThorax, 1967
- The Isolation and Some Properties of an Alkaloid from Crotalaria spectabilis Roth1Journal of the American Chemical Society, 1935